Multiple MyelomaTerminally IllPalliative CareParenteral Nutrition, Home TotalTerminal CareBoronic AcidsAntineoplastic AgentsPyrazinesMedical FutilityLeukemia, Lymphocytic, Chronic, B-CellWidowhoodNeoplasmsCell Line, TumorWaldenstrom MacroglobulinemiaLymphoma, FollicularLymphoma, Mantle-CellAttitude to DeathTruth DisclosurePlasma CellsApoptosisAntineoplastic Combined Chemotherapy ProtocolsMedical OncologyTreatment OutcomeMice, SCIDMolecular Targeted TherapyThalidomideXenograft Model Antitumor AssaysDisease Models, AnimalPrognosisDisease ProgressionBrain NeoplasmsSignal TransductionGlioblastomaCombined Modality TherapyCell ProliferationClinical Trials as TopicGliomaGene Expression Regulation, NeoplasticNeoplasm MetastasisCell SurvivalParaproteinemiasDrug Resistance, NeoplasmStem Cell TransplantationGenetic TherapySurvival RateProstatic NeoplasmsTransplantation, HeterologousProto-Oncogene Proteins c-bcl-2Proteasome InhibitorsMedulloblastomaRadioimmunotherapySurvival AnalysisMyeloid Cell Leukemia Sequence 1 ProteinOncolytic VirotherapyTumor Cells, CulturedQuality of LifeImmunotherapyNeoplastic Stem CellsBone NeoplasmsDisease-Free SurvivalAndrogen AntagonistsNeoplasm StagingTime FactorsMutationHuntington DiseaseReceptors, AndrogenNeoplasm TransplantationTumor BurdenAntibodies, Monoclonal, Murine-DerivedAdenocarcinomaCell Growth ProcessesModels, BiologicalPancreatic NeoplasmsAntibodies, MonoclonalAmyotrophic Lateral SclerosisMice, NudeNeoplasm InvasivenessGene Expression ProfilingLymphoma, B-CellDrug Evaluation, PreclinicalDrug SynergismLymphoma, Non-HodgkinLung NeoplasmsMice, TransgenicQuestionnairesDose-Response Relationship, DrugProtease InhibitorsHematopoietic Stem Cell TransplantationDrug Administration ScheduleBreast NeoplasmsRecurrenceImmunohistochemistryBone MarrowDown-RegulationCell DeathTransplantation ConditioningRNA, Small InterferingRNA InterferenceNeoplasm Recurrence, LocalTumor Markers, Biological